How Sugars, Surfactants and Proteins Work Together in Conjugate Pad Treatment Buffers
A conjugate pad treatment buffer should keep the labeled reagent stable during drying and storage, then enable fast, even and controlled release when the sample arrives. Sugars, nonionic surfactants and proteins are three of the most common variables adjusted during lateral flow assay development.
Roles of the three key component groups
Sugars help protect labeled reagents during drying, support re-dissolution and influence release kinetics. Sucrose and trehalose are common options, and a typical starting validation range may be designed between 0.5% and 2%. Trehalose is often considered for drying protection, while cost and project compatibility still need to be verified.
Nonionic surfactants improve fiber rewetting, lower surface tension and help detach labeled particles from the pad. Tween 20 is relatively gentle; Triton X-100 is stronger and should be evaluated carefully for its impact on marker stability and background. A practical starting range is often 0.05% to 0.5%, adjusted in small steps.
Proteins such as BSA can block fiber surfaces, stabilize conjugates and reduce nonspecific adsorption. A validation range of 0.5% to 3% is common, but more protein is not always better because high levels may increase viscosity and slow release.
A conservative starting screen
When there is no historical formulation, the buffer system, sugar, surfactant and protein can be separated into measurable variables. One starting screen may use 10 to 50 mM PB or Tris at pH 7.4 to 8.0, combined with around 1% sugar, 0.2% Tween 20 and 1% BSA.
This should not be treated as a universal formula. It is a starting framework for observing pad residue, T/C line intensity, membrane background, running time, negative-sample behavior and signal change after storage.
Troubleshooting release and background
If visible color or fluorescence remains on the conjugate pad after running, first check rewetting speed, sugar protection, surfactant-assisted release, protein level and drying conditions. Sugars or surfactants may be increased step by step while monitoring background.
If release is fast but the negative background becomes dirty, check whether sugar or surfactant is excessive, blocking is insufficient, spray amount is too high or the NC membrane accepts flow too aggressively. Lowering surfactant or sugar and increasing blocking can be compared.
If the T line is weak, do not assume the pad is the only cause. Confirm complete release first, then evaluate conjugate activity, coupling quality, antibody-antigen matching, NC membrane capture and reader window.
Directions for different assay types
Colloidal gold and colored microsphere projects usually balance complete release with clean background. A starting direction may include 0.5% to 1% sugar, 0.1% to 0.3% Tween 20 and 1% to 2% BSA.
Fluorescent microsphere assays are more background-sensitive. Lower surfactant levels, stronger protein blocking and trehalose-containing designs are often compared, with blank-background controls to avoid amplifying fluorescence noise.
Whole blood projects are affected by viscosity, red blood cells and matrix components, so treatment buffers should be evaluated together with sample pads, blood filtration materials and downstream membranes. High-viscosity samples require extra attention to rewetting, spreading pattern and flow stability.
Common formulation mistakes
Excessive sugar may leave the pad sticky or hygroscopic after drying and may reduce release stability during storage.
More surfactant does not always mean better release; high levels may affect marker stability, antibody conformation or negative background.
Protein blocking can reduce nonspecific adsorption, but too much protein may form a thicker dried layer and increase release resistance.
Different markers, sample types and strip structures require different treatment strategies. Small-scale screening, repeatability checks and stability verification are necessary before production adoption.
JY Biotech application note
Shanghai JY Biotechnology has served the rapid diagnostic industry for 18 years. For conjugate pad buffer optimization, JY Biotech recommends evaluating material model, treatment buffer, spray amount, drying humidity and temperature, NC membrane, absorbent driving force and sample type in one validation plan.
Customers can discuss Ahlstrom diagnostic materials such as 8964, 6613, 8951, 141 and 142, as well as GL0194, fluorescent nanobeads, blood filtration materials, GF2 and H5072. JY Biotech can support sample adoption, material substitution evaluation, background troubleshooting, sensitivity improvement and supply coordination.
FAQ
Why not publish one fixed conjugate pad treatment formula?
Because buffer performance is influenced by marker, sample, pad material, NC membrane, drying condition and reader window. A website guide should provide starting ranges and troubleshooting logic, while the final formulation must be confirmed by project validation.
What should be adjusted first when release is incomplete?
Start by observing rewetting speed and pad residue, then compare sugar, surfactant and protein levels in small steps while checking drying condition, spray amount and absorbent driving force.
Why are surfactants more sensitive in fluorescent microsphere projects?
Fluorescence assays are more sensitive to background noise. Some surfactants or additives may amplify background or affect conjugate stability, so low-level gradients and blank-background controls are important.
Should the treatment buffer be revalidated during import substitution?
Yes. If the fiber structure, absorbency or surface state changes, the original buffer may no longer behave the same way and should be verified with the candidate replacement material.
RELATED